에난타제약(주)
US ˙ NasdaqGS ˙ US29251M1062

SecurityENTA / Enanta Pharmaceuticals, Inc.
InstitutionPrudential Financial Inc
Latest Disclosed Ownership37,995 shares
Latest Disclosed Value $ 479,877
Prudential Financial Inc reports 5.05% decrease in ownership of ENTA / Enanta Pharmaceuticals, Inc.

On May 13, 2026 - Prudential Financial Inc filed a 13F-HR form disclosing ownership of 37,995 shares of Enanta Pharmaceuticals, Inc. (US:ENTA) valued at $479,877 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 40,015 shares of Enanta Pharmaceuticals, Inc.. This represents a change in shares of -5.05% during the quarter. The current value of the position is $445,681 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F ENANTA PHARMACEUTICALS COM 29251M106 37,995 -2,020 -5.05 480 -24.09 0.0003
2026-02-13 2025-12-31 13F ENANTA PHARMACEUTICALS COM 29251M106 40,015 40,015 631 0.0008
2025-05-13 2025-03-31 13F ENANTA PHARMACEUTICALS COM 29251M106 0 -60,364 -100.00 0 -100.00
2025-02-11 2024-12-31 13F ENANTA PHARMACEUTICALS COM 29251M106 60,364 -96,700 -61.57 347 -78.67 0.0005
2024-11-14 2024-09-30 13F ENANTA PHARMACEUTICALS COM 29251M106 157,064 0 0.00 1,627 -20.13 0.0023
2024-08-13 2024-06-30 13F ENANTA PHARMACEUTICALS COM 29251M106 157,064 -15,200 -8.82 2,037 -32.26 0.0031
2024-05-14 2024-03-31 13F ENANTA PHARMACEUTICALS COM 29251M106 172,264 -21,300 -11.00 3,008 65.13 0.0042
2024-02-13 2023-12-31 13F ENANTA PHARMACEUTICALS COM 29251M106 193,564 13,500 7.50 1,821 -9.45 0.0028
2023-11-13 2023-09-30 13F ENANTA PHARMACEUTICALS COM 29251M106 180,064 147,812 458.30 2,011 191.45 0.0032
2023-08-11 2023-06-30 13F ENANTA PHARMACEUTICALS COM 29251M106 32,252 -10,747 -24.99 690 -60.30 0.0010
2023-05-12 2023-03-31 13F ENANTA PHARMACEUTICALS COM 29251M106 42,999 23,250 117.73 1,739 89.32 0.0027
2023-02-14 2022-12-31 13F ENANTA PHARMACEUTICALS COM 29251M106 19,749 0 0.00 919 -10.35 0.0015
2022-11-04 2022-09-30 13F ENANTA PHARMACEUTICALS COM 29251M106 19,749 860 4.55 1,024 14.67 0.0017
2022-08-15 2022-06-30 13F ENANTA PHARMACEUTICALS COM 29251M106 18,889 -405 -2.10 893 -34.96 0.0014
2022-05-13 2022-03-31 13F ENANTA PHARMACEUTICALS COM 29251M106 19,294 139 0.73 1,373 -4.12 0.0018
2022-02-14 2021-12-31 13F ENANTA PHARMACEUTICALS COM 29251M106 19,155 -255 -1.31 1,432 29.83 0.0018
2021-11-15 2021-09-30 13F ENANTA PHARMACEUTICALS COM 29251M106 19,410 -130 -0.67 1,103 28.26 0.0015
2021-08-16 2021-06-30 13F ENANTA PHARMACEUTICALS COM 29251M106 19,540 -1,006 -4.90 860 -15.10 0.0012
2021-05-12 2021-03-31 13F ENANTA PHARMACEUTICALS COM 29251M106 20,546 -363 -1.74 1,013 15.11 0.0015
2021-08-16 2020-12-31 13F/A-1 ENANTA PHARMACEUTICALS COM 0042 29251M106 20,909 -2,640 -11.21 880 -18.37 0.0015
2021-02-16 2020-12-31 13F ENANTA PHARMACEUTICALS COM 29251M106 20,909 -2,640 880 0.0015
2020-11-16 2020-09-30 13F ENANTA PHARMACEUTICALS COM 29251M106 23,549 2,247 10.55 1,078 0.75 0.0020
2020-08-12 2020-06-30 13F ENANTA PHARMACEUTICALS COM 29251M106 21,302 -4,264 -16.68 1,070 -18.63 0.0021
2020-05-12 2020-03-31 13F ENANTA PHARMACEUTICALS COM 29251M106 25,566 -50,141 -66.23 1,315 -71.89 0.0029
2020-02-11 2019-12-31 13F ENANTA PHARMACEUTICALS COM 29251M106 75,707 42,377 127.14 4,678 133.55 0.0069
2019-11-13 2019-09-30 13F ENANTA PHARMACEUTICALS COM 29251M106 33,330 -334 -0.99 2,003 -29.50 0.0032
2019-08-08 2019-06-30 13F ENANTA PHARMACEUTICALS COM 29251M106 33,664 650 1.97 2,841 -9.90 0.0044
2019-05-15 2019-03-31 13F ENANTA PHARMACEUTICALS COM 29251M106 33,014 -6,215 -15.84 3,153 13.50 0.0053
2019-02-07 2018-12-31 13F ENANTA PHARMACEUTICALS COM 29251M106 39,229 -180,586 -82.15 2,778 -85.21 0.0049
2018-11-07 2018-09-30 13F ENANTA PHARMACEUTICALS COM 29251M106 219,815 -82,772 -27.35 18,785 -46.44 0.0277
2018-08-13 2018-06-30 13F ENANTA PHARMACEUTICALS COM 29251M106 302,587 85,397 39.32 35,070 99.57 0.0524
2018-05-04 2018-03-31 13F ENANTA PHARMACEUTICALS COM 29251M106 217,190 124,458 134.21 17,573 222.97 0.0268
2018-02-13 2017-12-31 13F ENANTA PHARMACEUTICALS COM 29251M106 92,732 46,135 99.01 5,441 149.47 0.0074
2017-11-02 2017-09-30 13F ENANTA PHARMACEUTICALS COM 29251M106 46,597 490 1.06 2,181 31.46 0.0036
2017-08-07 2017-06-30 13F ENANTA PHARMACEUTICALS COM 29251M106 46,107 -23,564 -33.82 1,659 -22.69 0.0025
2017-05-10 2017-03-31 13F ENANTA PHARMACEUTICALS COM 29251M106 69,671 20,743 42.39 2,146 30.93 0.0033
2017-02-07 2016-12-31 13F ENANTA PHARMACEUTICALS COM 29251M106 48,928 -32,476 -39.89 1,639 -24.33 0.0026
2016-11-04 2016-09-30 13F ENANTA PHARMACEUTICALS COM 29251M106 81,404 34,330 72.93 2,166 108.67 0.0036
2016-08-09 2016-06-30 13F ENANTA PHARMACEUTICALS COM 29251M106 47,074 -1,640 -3.37 1,038 -27.46 0.0017
2016-05-09 2016-03-31 13F ENANTA PHARMACEUTICALS COM 29251M106 48,714 18,344 60.40 1,431 42.67 0.0026
2016-02-12 2015-12-31 13F ENANTA PHARMACEUTICALS COM 29251M106 30,370 600 2.02 1,003 -6.78 0.0018
2015-11-10 2015-09-30 13F ENANTA PHARMACEUTICALS COM 29251M106 29,770 -15,200 -33.80 1,076 -46.81 0.0021
2015-08-06 2015-06-30 13F ENANTA PHARMACEUTICALS COM 29251M106 44,970 44,970 0.00 2,023 0.0036
2015-02-06 2014-12-31 13F ENANTA PHARMACEUTICALS COM 29251M106 0 -14,970 -100.00 0 -100.00
2014-11-12 2014-09-30 13F ENANTA PHARMACEUTICALS COM 29251M106 14,970 -100 -0.66 592 44.04 0.0011
2014-02-11 2013-12-31 13F ENANTA PHARMACEUTICALS COM 29251M106 15,070 15,070 411 0.0008
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.